Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Fecal DNA Methylation and Helicobacter Pylori Gastric Cancer Susceptibility Genes for the Early Diagnosis and Screening of Gastric Cancer

NCT06943768 is registered in ClinicalTrials.gov with Fudan University as lead sponsor.

NCT NCT06943768
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06943768 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Fecal DNA Methylation and Helicobacter Pylori Gastric Cancer Susceptibility Genes for the Early Diagnosis and Screening of Gastric Cancer
Lead sponsor
Fudan University
Phase
Observational
Overall status
Not yet recruiting
Start date
December 1, 2025
Completion date
June 30, 2026
Enrollment
9,654 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

gastric (stomach) cancer